<DOC>
	<DOCNO>NCT01597349</DOCNO>
	<brief_summary>The purpose research study learn effective safe FP01 lozenge give subject cough due upper respiratory tract infection . The study include subject upper respiratory tract infection , cough less six week duration .</brief_summary>
	<brief_title>Antitussive Effects FP01 Lozenges Subjects With Cough Due Upper Respiratory Tract Infection</brief_title>
	<detailed_description />
	<mesh_term>Cough</mesh_term>
	<mesh_term>Respiratory Tract Infections</mesh_term>
	<mesh_term>Antitussive Agents</mesh_term>
	<mesh_term>Guaifenesin</mesh_term>
	<mesh_term>Phenylpropanolamine</mesh_term>
	<mesh_term>Chlorpheniramine , phenylpropanolamine drug combination</mesh_term>
	<criteria>gastroesophageal INCLUSION CRITERIA 1 . Subject must state `` cold '' &lt; 14 day . A `` cold '' define : Moderate severe rhinorrhea ( i.e. , use 2 tissue per hour 1 hour within 12 hour precede study screening AND At least one respiratory symptom ( cough , pharyngeal symptom [ sore throat ] , nasal congestion moderate severe intensity , headache , etc . ) 2 . Subject must exceed cough severity threshold ( VAS ) screen visit ( Cough Severity VAS score ≥ 40 mm ) . 3 . Subjects recall average number day cough usual cold history 3 great ( URTI cough history &gt; 3 ) . 4 . Subjects smoke use nicotine nicotine containing product . Exsmokers/extobacco user must stop use tobacco product least 6 month prior study screen . 5 . Female subject either postmenopausal ( amenorrhea least 12 consecutive month ) , surgically sterile , woman childbearing potential ( WOCP ) negative serum beta human chorionic gonadotropin ( HCG ) pregnancy test prior enter study use agree use acceptable method contraception determine Investigator . Acceptable contraceptive include abstinence OR intrauterine device ( IUDs ) , hormonal contraceptive ( oral , depot , patch injectable ) ≥ three month prior screen OR use double barrier method condom diaphragms spermicidal gel foam . 6 . Subject must sign Institutional Review Board approve inform consent agree complete require clinic visit . EXCLUSION CRITERIA 1 . Subject use antibiotic study screen antibiotic currently indicate determine Investigator . 2 . History cough great 6 week duration . 3 . History chronic pulmonary disease include tuberculosis , lung cancer , chronic bronchitis emphysema 4 . History pneumonia , influenza whooping cough within past 30 day . 5 . History asthma require treatment within 2 week study 6 . T &gt; 38.5oC history antipyretic medication &gt; 24 hour screen visit 7 . History inhalational exposure ( chemical , smoke , water , etc . ) within past 6 month 8 . Chest Xray suggestive granulomatous disease , malignancy , COPD , bronchiectasis , pneumonia , pleural process underlie pulmonary disease 9 . Active , concurrent concomitant disease might limit ability subject participate study determine Investigator ( i.e. , diabetes mellitus , congestive heart failure , unstable angina , etc . ) 10 . Prior current renal disease ; calculate creatinine clearance &lt; 30 ml/min ( calculate ClCr &lt; 30 ) 11 . Known immune deficiency condition 12 . Use opioids anticonvulsant within 3 day study screen . 13 . Known hypersensitivity memantine lozenge excipients . 14 . Current oral lesion abnormal finding buccal examination do study screen . 15 . History oropharyngeal gastroesophageal carcinoma , gastro/esophageal/duodenal resection . 16 . Subject clinically significant abnormal laboratory test result screen visit . ( Subject may enrol exception , determine Principal Investigator consent Cerecor 's Medical Monitor . ) 17 . Any clinically significant find ECG do screen visit , determine investigator . ( Subject may enrol exception , determine Principal Investigator consent Cerecor 's Medical Monitor ) . 18 . Female subject pregnant , breast feeding sexually active without contraception . 19 . Subject donate blood plasma within last 45 day . 20 . Subject history alcohol drug abuse past 2 year . 21 . Subject positive drug screen . 22 . Subject positive HIV , Hepatitis B Hepatitis C test .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2014</verification_date>
</DOC>